ACCURAY INC(ARAY)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,739 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ARAY Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for ACCURAY INC (ARAY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ARAY at 23.0/100 on a 32-signal composite quality model, placing it at rank #2,739 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (3.6) and revenue growth (12.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ACCURAY INC reports quarterly revenue of $100.9M, net income of $-1.9M, free cash flow of $2.0M. Top institutional holders of ARAY by reported 13-F value include TCW GROUP, Neuberger Berman Group, ARMISTICE CAPITAL, based on the most recent SEC filings. ARAY trades on the Nasdaq exchange and files with the SEC under CIK 1138723. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARAY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACCURAY INC directly from SEC EDGAR. ACCURAY INC's 13F Pro composite quality score has ranged between 23 and 41 since 2021, currently 23.0 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$100.9M
Net Income
Q2 2026
$-1.9M
Free Cash Flow
Q2 2026
$2.0M
ROIC
Q2 2026
11.6%
D/E Ratio
Q2 2026
3.58
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-12.3% YoYNet Income
-2992.0% YoYOperating Income
-437.3% YoYEPS (Diluted)
Total Assets
-5.6% YoYTotal Debt
-7.8% YoYOp. Cash Flow
-344.1% YoYFree Cash Flow
-809.5% YoY| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $401.9M -12.3% | $458.5M +2.7% | $446.6M -0.2% | $447.6M +4.1% | $429.9M +8.5% | $396.3M |
| Net Income | $-49.2M -2992.0% | $-1.6M +89.8% | $-15.5M -67.5% | $-9.3M -73.6% | $-5.3M +15.3% | $-6.3M |
| Operating Income | $-26.4M -437.3% | $7.8M +1455.4% | $504.0K -78.8% | $2.4M -70.8% | $8.1M -63.4% | $22.2M |
| EPS (Diluted) | — | $-0.02 +87.5% | $-0.16 -60.0% | $-0.10 -66.7% | $-0.06 +14.3% | $-0.07 |
| Total Assets | $443.7M -5.6% | $470.2M +0.3% | $468.6M -2.2% | $479.2M +1.3% | $472.8M -1.5% | $480.1M |
| Total Debt | $149.4M -7.8% | $162.0M -13.7% | $187.7M -0.6% | $188.7M -4.5% | $197.6M +8.9% | $181.4M |
| Operating Cash Flow | $-7.0M -344.1% | $2.9M +124.0% | $-11.9M -176.6% | $15.5M +747.5% | $-2.4M -106.2% | $38.5M |
| Free Cash Flow | $-12.8M -809.5% | $-1.4M +90.9% | $-15.5M -630.1% | $2.9M +141.1% | $-7.1M -119.7% | $36.2M |
Get alerted when ARAY's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ACCURAY INC including:
Top Institutional Holders of ARAY
TCW GROUP INC
$4.1M18,942,059 shNeuberger Berman Group LLC
$1.6M6,073,663 shARMISTICE CAPITAL, LLC
$1.5M5,736,000 shWEBER CAPITAL MANAGEMENT LLC /ADV
$1.3M4,932,706 shVANGUARD CAPITAL MANAGEMENT LLC
$1.1M4,437,800 shBlackRock, Inc.
$842.0K3,266,185 shAQR CAPITAL MANAGEMENT LLC
$701.0K2,719,032 shJANE STREET GROUP, LLC
$551.6K2,139,720 shRENAISSANCE TECHNOLOGIES LLC
$532.4K2,065,284 shDAFNA Capital Management LLC
$433.2K1,680,508 sh
| Fund | Value | Shares |
|---|---|---|
| TCW GROUP INC | $4.1M | 18,942,059 |
| Neuberger Berman Group LLC | $1.6M | 6,073,663 |
| ARMISTICE CAPITAL, LLC | $1.5M | 5,736,000 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | $1.3M | 4,932,706 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1M | 4,437,800 |
| BlackRock, Inc. | $842.0K | 3,266,185 |
| AQR CAPITAL MANAGEMENT LLC | $701.0K | 2,719,032 |
| JANE STREET GROUP, LLC | $551.6K | 2,139,720 |
| RENAISSANCE TECHNOLOGIES LLC | $532.4K | 2,065,284 |
| DAFNA Capital Management LLC | $433.2K | 1,680,508 |
Companies Similar to ARAY
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
IRIDEX CORP
ANGIODYNAMICS INC
TREACE MEDICAL CONCEPTS, INC.
Inogen Inc
NEOGEN CORP
Anika Therapeutics, Inc.
Orthofix Medical Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put ARAY on your watchlist
Track score changes the day ACCURAY INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ARAY a good stock to buy?
13F Pro's AI-powered analysis of ACCURAY INC (ARAY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ARAY are available on the ARAY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ARAY is classified as a small company.
Which hedge funds own ARAY?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ARAY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ACCURAY INC's investment landscape.